NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2025
Back to search
Official data from USPTO
NATURALIA MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/12/2025
Classification
Registered
Trademark type
Combined
Nice classes
3, 5
Filing date
01/13/2020
Registration date
10/20/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2020
Last transaction
12/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
CIANCI,RYAN MICHAEL
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a molecule to the left of the stylized wording "NATURALIA MEDICAL".
Holders and representatives
Holders
Naturalia Sintesi S.r.l.
Representatives
Francesco Braga Perani & Partners S.p.A.
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics
Class 5
Pharmaceuticals, namely medicated creams and lotions for the skin care
Publications
History of USPTO decisions and trademark events.
30 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/20/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/08/2021
FIMP
FINAL DISPOSITION PROCESSED
02/08/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/20/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2020
PUBO
PUBLISHED FOR OPPOSITION
08/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/31/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2020
ALIE
ASSIGNED TO LIE
07/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/25/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/25/2020
RFNT
REFUSAL PROCESSED BY IB
05/09/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/22/2020
RFRR
REFUSAL PROCESSED BY MPU
04/21/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/02/2020
CNRT
NON-FINAL ACTION WRITTEN
04/01/2020
DOCK
ASSIGNED TO EXAMINER
03/30/2020
MAFR
APPLICATION FILING RECEIPT MAILED
03/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/12/2020
Continuous trademark protection
Get notified about every new filing that threatens NATURALIA MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.